Résumé
Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.
Détails
Titre
Glycotargeting therapeutics
Auteur(s)
Hubbell, Jeffrey A ; Wilson, David Scott
Date
2017
Mots-clés (libres)
Note
Alternative title(s) :
(de) Glyco-targetierende therapeutika
(fr) Agents thérapeutiques de glycociblage
Autres identifiant(s)
EPO Family ID: 57730362
EPO Family ID: 56692928
EPO Family ID: 53762221
EPO Family ID: 57121450
EPO Family ID: 56692928
EPO Family ID: 53762221
EPO Family ID: 57121450
Numéro(s) de brevet
EP4385520 (A2)
JP2024063005 (A)
CN108430497 (B)
JP2024037920 (A)
JP7434248 (B2)
IL257958 (B2)
IL306015 (A)
US11801305 (B2)
US11793882 (B2)
IL257958 (B1)
CA2946064 (C)
AU2023203475 (A1)
US11666638 (B2)
IL283100 (B2)
US11654188 (B2)
US2023119325 (A1)
US2023115331 (A1)
US2023108299 (A1)
US2023093483 (A1)
AU2016325073 (B2)
KR20230003288 (A)
JP7082045 (B2)
JP2022070910 (A)
JP2022028673 (A)
MX2021012636 (A)
EP3909603 (A1)
ES2874884 (T3)
LT3107563 (T)
IL283100 (A)
IL247283 (B)
DK3107563 (T3)
EP3107563 (B1)
AU2021201504 (A1)
US10953101 (B2)
US10946079 (B2)
US10940209 (B2)
SG10202010936R (A)
EA036102 (B9)
AU2015233084 (B2)
US10821157 (B2)
EA036102 (B1)
JP6744227 (B2)
JP2020121981 (A)
US2020129629 (A1)
US2020129601 (A1)
US2020129625 (A1)
US2020121762 (A1)
HK1257845 (A1)
JP2018532722 (A)
US2018303951 (A1)
BR112018005409 (A2)
US2018271986 (A1)
MX2018003411 (A)
EA201890778 (A1)
CN108430497 (A)
US10046056 (B2)
EP3349784 (A1)
KR20180080195 (A)
IL257958 (A)
AU2016325073 (A1)
NZ723879 (A)
HK1232151 (A1)
US2017296636 (A9)
BR112016019274 (A2)
MX2016010835 (A)
EA201691686 (A1)
CA2998066 (A1)
WO2017046652 (A1)
JP2017507180 (A)
CN106456743 (A)
US2017007708 (A1)
EP3107563 (A2)
KR20160135214 (A)
SG11201606761R (A)
AU2015233084 (A1)
US2016243248 (A1)
US2016015821 (A1)
WO2015140648 (A3)
CA2946064 (A1)
WO2015140648 (A2)
JP2024063005 (A)
CN108430497 (B)
JP2024037920 (A)
JP7434248 (B2)
IL257958 (B2)
IL306015 (A)
US11801305 (B2)
US11793882 (B2)
IL257958 (B1)
CA2946064 (C)
AU2023203475 (A1)
US11666638 (B2)
IL283100 (B2)
US11654188 (B2)
US2023119325 (A1)
US2023115331 (A1)
US2023108299 (A1)
US2023093483 (A1)
AU2016325073 (B2)
KR20230003288 (A)
JP7082045 (B2)
JP2022070910 (A)
JP2022028673 (A)
MX2021012636 (A)
EP3909603 (A1)
ES2874884 (T3)
LT3107563 (T)
IL283100 (A)
IL247283 (B)
DK3107563 (T3)
EP3107563 (B1)
AU2021201504 (A1)
US10953101 (B2)
US10946079 (B2)
US10940209 (B2)
SG10202010936R (A)
EA036102 (B9)
AU2015233084 (B2)
US10821157 (B2)
EA036102 (B1)
JP6744227 (B2)
JP2020121981 (A)
US2020129629 (A1)
US2020129601 (A1)
US2020129625 (A1)
US2020121762 (A1)
HK1257845 (A1)
JP2018532722 (A)
US2018303951 (A1)
BR112018005409 (A2)
US2018271986 (A1)
MX2018003411 (A)
EA201890778 (A1)
CN108430497 (A)
US10046056 (B2)
EP3349784 (A1)
KR20180080195 (A)
IL257958 (A)
AU2016325073 (A1)
NZ723879 (A)
HK1232151 (A1)
US2017296636 (A9)
BR112016019274 (A2)
MX2016010835 (A)
EA201691686 (A1)
CA2998066 (A1)
WO2017046652 (A1)
JP2017507180 (A)
CN106456743 (A)
US2017007708 (A1)
EP3107563 (A2)
KR20160135214 (A)
SG11201606761R (A)
AU2015233084 (A1)
US2016243248 (A1)
US2016015821 (A1)
WO2015140648 (A3)
CA2946064 (A1)
WO2015140648 (A2)
Le document apparaît dans
Production scientifique et compétences > SV - Faculté des sciences de la vie > SV Archives > LMRP - Laboratoire de médecine régénérative et de pharmacobiologie
Production scientifique et compétences > SB - Faculté des sciences de base > SB Archives > LMRP - Laboratoire de médecine régénérative et de pharmacobiologie
Production scientifique et compétences > Unités non-académiques > TTO - Office de transfert de technologies
Travail produit à l'EPFL
Brevets
Production scientifique et compétences > SB - Faculté des sciences de base > SB Archives > LMRP - Laboratoire de médecine régénérative et de pharmacobiologie
Production scientifique et compétences > Unités non-académiques > TTO - Office de transfert de technologies
Travail produit à l'EPFL
Brevets
Date de création de la notice
2017-05-02